Boston Strategics Announces Oncology Drug Development Partnership With …

Published December 3, 2013

Boston Strategics Announces Oncology Drug Development Partnership with …

Filed under: Houston Drug Treatment Help

In this capacity, Boston Strategics will leverage its "True Open InnovationTM" network to deliver superior outcomes, using highly efficient execution strategies and proven partners, such as the University of Texas MD Anderson Cancer Center, Houston TX …
Read more on 4-traders (press release)

Experimental drug reduces brain damage, eliminates brain hemorrhaging in …

Filed under: Houston Drug Treatment Help

The study, which appears online in the journal Stroke, provides additional evidence that 3K3A-APC may be used as a therapy for stroke in humans, either alone or in combination with the FDA-approved clot-busting drug therapy tPA (tissue plasminogen …
Read more on The Almagest

Wednesday letters: Algebra 2, Gary Kubiak

Filed under: Houston Drug Treatment Help

Rapid response to a TIA and adherence to a treatment plan can prevent occurrence of a full-blown stroke. There is just one type of drug approved to treat strokes: a clot-buster called tissue plasminogen activator, or tPA. It must be administered within …
Read more on Houston Chronicle